-
Cancer Immunotherapy Market Research Report 2025-2029: Curing Cancer Is Generating Enormous New Markets - How Big Are They? Where Is The Opportunity?
26 Dec 2024 10:00 GMT
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides" report has …
-
Bio-Thera Solutions Partners With Tabuk Pharmaceuticals To Commercialize BAT2206, A Stelara® (Ustekinumab) Biosimilar In Saudi Arabia
24 Dec 2024 13:51 GMT
(MENAFN- PR Newswire)
BAT2206 is a proposed biosimilar to Jansen's Stelara®. Bio-Thera has filed for regulatory approval of BAT2206 with the China National Medical Products Administration (NMPA), the European Medicines Agency (EMA) and the United …
-
Pharmaceuticals & Medicine Manufacturing Market Set to Surge at 8.9% CAGR, to Reach US$ 2,516.46 Million by 2034 | Fact.MR Report
24 Dec 2024 11:30 GMT
Rockville, MD , Dec. 24, 2024 (GLOBE NEWSWIRE) -- According to the newly released report by Fact.MR, a market research and competitive intelligence provider, the global Pharmaceuticals & Medicine Manufacturing Market is evaluated to reach US$ 1,073.08 …
-
What’s on pharmacy leaders' radars for 2025
23 Dec 2024 19:52 GMT
Becker's asked pharmacy executives from hospitals and health systems across the U.S. to share the areas they're focusing on for 2025.
The 10 executives featured in this article are all speaking at the Becker's Healthcare Spring Chief Pharmacy …
-
Gynecological Cancer Drugs Research Report 2024: Personalized Medicine Revolutionizes Gynecological Cancer Care With Targeted Therapies - Explore Potential $24 Billion Opportunities By 2030
23 Dec 2024 18:34 GMT
(MENAFN- GlobeNewsWire - Nasdaq) Understand the significant growth trajectory of the Cervical Cancer Drugs segment, which is expected to reach US$10.3 Billion by 2030 with a CAGR of a 5.7%. The Uterine Cancer Drugs segment is also set to grow at 5.1% CAGR …
-
Gynecological Cancer Drugs Market Research Report 2024-2030: Impact of Biosimilars and Generics on the Market, Innovations in Immunotherapy and Personalized Medicine Propel Market Growth - ResearchAndMarkets.com
23 Dec 2024 17:22 GMT
The "Gynecological Cancer Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Gynecological Cancer Drugs was estimated at US$16.9 Billion in 2023 and is projected to …
-
Green Chemistry Market Report 2024: Pharma Leaders Embrace Biocatalysis and Renewable Processes, Spurring Green Chemistry Boom - ResearchAndMarkets.com
23 Dec 2024 16:39 GMT
The "Green Chemistry Market: Focus on Green Chemistry Initiatives, Competitive Landscape of Green Chemistry Solution Providers, Emerging Mega Trends, Big Pharma Initiatives, Company Profiles and Key Drivers and Restraints" report has been added …
-
Cardiology Year in Review: 2024
26 Dec 2024 15:06 GMT
The past year has been a defining one for cardiology, marked by groundbreaking approvals and pivotal clinical trial announcements that are set to shape the future of cardiovascular care. The cardiology community has been abuzz with significant developments …
-
Vascular Dementia Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies By Delveinsight
26 Dec 2024 13:04 GMT
(MENAFN- GetNews)
"Vascular Dementia treatment Market"Vascular Dementia Companies are Eisai Inc., Ever Neuro Pharma GmbH, Geny Research Corp, Novartis, Charsire Biotechnology Corp, Merz Pharmaceuticals GmbH, LLC Merz Pharma, Otsuka Pharmaceutical …
-
Our Top 5 Most Viewed Conference Video Interviews of 2024
24 Dec 2024 18:06 GMT
Below is a list of the most viewed video interviews from Applied Clinical Trials' on-site conference coverage in 2024.
1. DIA 2024: Ginny Beakes-Read of Johnson & Johnson Discusses Regulatory Challenges
In an interview at DIA 2024, Beakes-Read, …
About
© 1995-2024